Harmless herbs? A case report of acquired long QT syndrome and torsades de pointes in a patient taking herbal supplements

Cannabinoid Interactions with Cytochrome P450 Drug Metabolism: a Full-Spectrum Characterization

(2021) Peter T. Doohan et al.   AAPS Journal

The electrophysiological effect of cannabidiol on hERG current and in guinea-pig and rabbit cardiac preparations

(2020) Péter Orvos et al.   Scientific Reports

Synthetic Cannabinoids and Cardiac Arrhythmia Risk: Review of the Literature

(2019) Hayriye Mihrimah Ozturk et al.   Cardiovascular Toxicology

A Systematic Review on the Pharmacokinetics of Cannabidiol in Humans

(2018) Sophie A. Millar et al.   Frontiers in Pharmacology

Cannabidiol: State of the art and new challenges for therapeutic applications

(2017) Simona Pisanti et al.   PHARMACOLOGY & THERAPEUTICS

Meta-analysis of the effect and safety of berberine in the treatment of type 2 diabetes mellitus, hyperlipemia and hypertension

(2015) Jiarong Lan et al.   JOURNAL OF ETHNOPHARMACOLOGY

Repeated administration of berberine inhibits cytochromes P450 in humans

(2011) Ying Guo et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Evidence that the plant cannabinoid cannabigerol is a highly potent α2-adrenoceptor agonist and moderately potent 5HT1A receptor antagonist

(2009) MG Cascio et al.   BRITISH JOURNAL OF PHARMACOLOGY